Search

everythinglearnresearchcommunity

for

Search:↓

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Thyroxine (T4) may help heal skin wounds by promoting new skin and blood vessel growth.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

One cat with low thyroid hormone had growth issues, and another with high thyroid hormone had skin problems; both got better with treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

Mutations in certain receptors can cause diseases and offer new treatment options.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The man had pretibial myxedema and hyperthyroidism, causing skin changes and thyroid issues.

Levothyroxine treatment fully cured the young man's hypothyroid symptoms.

Hashimoto's can rarely change to Graves disease, needing careful monitoring.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Blocking certain proteins on immune cells may help treat alopecia areata.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Graves' disease is a common cause of hyperthyroidism, mainly in women, treated with medication, iodine, or surgery, with varying outcomes.